Zhejiang Shengda Pharm (603079) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Shengda Pharm (603079) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.27 Million ≈ $6.62 Million USD) by net assets (CN¥1.60 Billion ≈ $234.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Shengda Pharm (603079) net asset quality to measure how much of total assets are equity-financed.
Zhejiang Shengda Pharm - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Zhejiang Shengda Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Zhejiang Shengda Pharm cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Shengda Pharm Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Shengda Pharm ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Viva Biotech Holdings
F:VB0
|
0.041x |
|
Aramis SAS
PA:ARAMI
|
0.246x |
|
Jinan High tech Development Co Ltd
SHG:600807
|
-0.008x |
|
Morguard Real Estate Investment Trust
TO:MRT-UN
|
0.006x |
|
Wuxi Xinan Technology Co. Ltd. A
SHE:301170
|
N/A |
|
Syncmold Enterprise Corp
TW:1582
|
0.036x |
|
Mia Teknoloji AS
IS:MIATK
|
0.025x |
|
Zhuhai Kles Technology Co. Ltd. A
SHE:301314
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhejiang Shengda Pharm (2012–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Shengda Pharm from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Shengda Pharm market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.61 Billion ≈ $236.30 Million |
CN¥138.88 Million ≈ $20.32 Million |
0.086x | -25.32% |
| 2024-12-31 | CN¥1.28 Billion ≈ $187.89 Million |
CN¥147.88 Million ≈ $21.64 Million |
0.115x | +127.05% |
| 2023-12-31 | CN¥1.27 Billion ≈ $185.84 Million |
CN¥64.42 Million ≈ $9.43 Million |
0.051x | +67.37% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.59 Million |
CN¥40.72 Million ≈ $5.96 Million |
0.030x | -45.58% |
| 2021-12-31 | CN¥1.34 Billion ≈ $195.64 Million |
CN¥74.46 Million ≈ $10.90 Million |
0.056x | -77.85% |
| 2020-12-31 | CN¥1.33 Billion ≈ $193.90 Million |
CN¥333.20 Million ≈ $48.76 Million |
0.251x | +291.54% |
| 2019-12-31 | CN¥911.71 Million ≈ $133.41 Million |
CN¥58.55 Million ≈ $8.57 Million |
0.064x | -40.01% |
| 2018-12-31 | CN¥828.42 Million ≈ $121.22 Million |
CN¥88.69 Million ≈ $12.98 Million |
0.107x | -13.68% |
| 2017-12-31 | CN¥768.71 Million ≈ $112.49 Million |
CN¥95.33 Million ≈ $13.95 Million |
0.124x | -25.25% |
| 2016-12-31 | CN¥440.02 Million ≈ $64.39 Million |
CN¥73.00 Million ≈ $10.68 Million |
0.166x | -50.80% |
| 2015-12-31 | CN¥439.09 Million ≈ $64.25 Million |
CN¥148.07 Million ≈ $21.67 Million |
0.337x | +218.46% |
| 2014-12-31 | CN¥324.87 Million ≈ $47.54 Million |
CN¥34.40 Million ≈ $5.03 Million |
0.106x | -71.73% |
| 2013-12-31 | CN¥281.09 Million ≈ $41.13 Million |
CN¥105.28 Million ≈ $15.41 Million |
0.375x | -36.72% |
| 2012-12-31 | CN¥185.99 Million ≈ $27.22 Million |
CN¥110.08 Million ≈ $16.11 Million |
0.592x | -- |
About Zhejiang Shengda Pharm
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.